Follicle development and luteal cell morphology altered by phosphodiesterase-5 inhibitor

Micron

Volumn 40, Issue 8, 2009, Pages 845-850

  Donato, Mariana Aragão Matos ^a   Saraiva, Karina Lidianne Alcântara ^a,b   Silva, Amanda Karolina Soares e ^a   Wanderley, Maria Inês ^c   Peixoto, Christina Alves ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro de Tecnologias Estrategicas Do Nordeste   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Corpus luteum; Follicle; HDL; iPDE5; Ultrastructure

Indexed keywords

CORPUS LUTEUM; FOLLICLE; HDL; IPDE5; ULTRASTRUCTURE;

CELL MEMBRANES;

ENZYME INHIBITION;

ENZYME INHIBITOR; HIGH DENSITY LIPOPROTEIN; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE V; PIPERAZINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE; VARDENAFIL;

ANIMAL; ARTICLE; CHEMISTRY; CYTOCHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; LUTEAL CELL; MOUSE; OVARY FOLLICLE; SERUM; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ENZYME INHIBITORS; FEMALE; HISTOCYTOCHEMISTRY; IMIDAZOLES; LIPOPROTEINS, HDL; LUTEAL CELLS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; OVARIAN FOLLICLE; PIPERAZINES; SERUM; SULFONES; TRIAZINES;

MUS;

EID: 69249220122     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2009.06.007     Document Type: Article

References (25)

1. Ayala J.E., Bracy D.P., Julien B.M., Rottman J.N., Fueger P.T., and Wasserman D.H. Chronic treatment with Sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 56 4 (2007) 1025-1033
2. Behr-Roussel D., Oudot A., Compagnie S., Gorny D., Le Coz O., Bernabe J., Wayman C., Alexandre L., and Giuliano F. Impact of a long-term Sildenafil treatment on pressor response in conscious rats with insulin resistance and hypertriglyceridemia. Am. J. Hypertens. 21 11 (2008) 1258-1263
3. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411 (1999) 334-350
4. Hawkins D.E., Niswender K.D., Oss G.M., Moeller C.L., Odde K.G., Sawyer H.R., and Niswender G.D. An increase in serum lipids increases luteal lipid content and alters the disappearance rate of progesterone in cows. J. Anim. Sci. 73 2 (1995) 541-545
5. LaPolt P.S. Roles of cyclic GMP in modulating ovarian functions. Reprod. Biomed. Online 6 January-February (1) (2002) 15-23
6. Lugnier C., Schoeffter P., Le Bec A., Strouthou E., and Stoclet J.C. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem. Pharmacol. 35 May (10) (1986) 1743-1751
7. Lugnier C. Cyclic nucleotide phosphosdiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109 (2006) 366-398
8. Marcondes F.K., Bianchi F.J., and Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 62 4a (2002) 609-614
9. Martin W., Furchgott R.F., Villani G.M., and Jothianandan D. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 237 May (2) (1986) 539-547
10. McGee E., Spears N., Sawako M., Hsu S.Y., Chun S.Y., Billig H., and Hsueh A.J.W. Preantral ovarian follicles in serum-free culture: suppression of apoptosis after activation of the cyclic guanosine 3′,5′- monophosphate pathway and stimulation of growth and differentiation by follicle-stimulating hormone. Endocrinology 138 6 (1997) 2417-2424
11. Mehrotra N., Gupta M., Kovar A., and Meibohm B. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int. J. Impot. Res. 19 May-June (3) (2007) 253-264
12. Miranda-Jimenez L., and Murphy B.D. Lipoprotein receptor expression during luteinization of the ovarian follicle. Am. J. Physiol. Endocrinol. Metab. 293 (2007) 1053-1061
13. Mukhopadhyay A.K., and Leidenberger F.A. Effect of a tumour-promoting phorbol ester on atrial peptide-induced testosterone production and cyclic GMP accumulation by isolated mouse Leydig cells. Mol. Cell. Endocrinol. 56 1-2 (1988) 171-176
14. Myers M., Britt K.L., Wreford N.G.M., Ebling F.J.P., and Kerr J.B. Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127 (2004) 569-580
15. Niswender G.D. Molecular control of luteal secretion of progesterone. Reproduction 123 (2002) 333-339
16. Pedersen T., and Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil. 17 3 (1968) 555-557
17. Peluso J.J. Progesterone as a regulator of granulosa cell viability. J. Steroid Biochem. Mol. Biol. 85 2-5 (2003) 167-173
18. Saraiva K., Silvajr V., Torres D., Donato M., Peres N., Souza J., and Peixoto C. Changes in mouse Leydig cells ultrastructure and testosterone secretion after diethylcarbamazine administration. Micron 39 (2008) 580-586
19. Sasseville, M., Guillemette, C., Coulombe, Z., Richard, F., 2005. Detection and potential role of 3′-5′cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase 5A (PDE5A) in porcine ovary. Fertil. Steril. v. 84, suplemment 1, page S397.
20. Schwarz E.R., Kapur V., Rodriguez J., Rastogi S., and Rosanio S. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int. J. Impot. Res. 19 (2007) 139-148
21. Scott J.E., Zhang P., and Hovatta O. Benefits of 8-bromoguanosine 3′,5′-cyclic monophosphate (8-Br-cGMP) in human ovarian cortical tissue culture. Reprod. Biomed. Online 8 March (3) (2004) 319-324
22. Stocco C., Telleria C., and Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr. Rev. 28 1 (2007) 117-149
23. Trigatti B., Rayburn H., Viñals M., Braun A., Miettinen H., Penman M., Hertz M., Schrenzel M., Amigo L., Rigotti A., and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. U.S.A. 96 August (16) (1999) 9322-9327
24. Zhao L., Mason N.A., Morrell N.W., Kojonazarov B., Sadykov A., Maripov A., Mirrakhimov M.M., Aldashev A., and Wilkins M.R. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104 (2001) 424-428
25. Wiltbank M.C., Belfiore C.J., and Niswender G.D. Steroidogenic enzyme activity after acute activation of protein kinase (PK) A and PKC in ovine small and large luteal cells. Mol. Cell. Endocrinol. 97 1-2 (1993) 1-7